On September 17, 2024, the following non-employee directors of the Board of Directors (the “Board”) of 23andMe Holding Co. (the “Company”) resigned from the Board (the “Resignations”), with such Resignations to be effective immediately: Roelof Botha, Patrick Chung, Sandra Hernández, M.D., Neal Mohan, Valerie Montgomery Rice, M.D., Richard Scheller, Ph.D., and Peter J. Taylor (collectively, the “Resigning Directors”).
Departed
Neal Mohan
Director
Chrome Holding Co.
Effective
2024-09-17
Filed
September 18, 2024, 7:59 PM ET
On September 17, 2024, the following non-employee directors of the Board of Directors (the “Board”) of 23andMe Holding Co. (the “Company”) resigned from the Board (the “Resignations”), with such Resignations to be effective immediately: Roelof Botha, Patrick Chung, Sandra Hernández, M.D., Neal Mohan, Valerie Montgomery Rice, M.D., Richard Scheller, Ph.D., and Peter J. Taylor (collectively, the “Resigning Directors”).
Departed
Sandra Hernández, M.D.
Director
Chrome Holding Co.
Effective
2024-09-17
Filed
September 18, 2024, 7:59 PM ET
On September 17, 2024, the following non-employee directors of the Board of Directors (the “Board”) of 23andMe Holding Co. (the “Company”) resigned from the Board (the “Resignations”), with such Resignations to be effective immediately: Roelof Botha, Patrick Chung, Sandra Hernández, M.D., Neal Mohan, Valerie Montgomery Rice, M.D., Richard Scheller, Ph.D., and Peter J. Taylor (collectively, the “Resigning Directors”).
Departed
Roelof Botha
Director
Chrome Holding Co.
Effective
2024-09-17
Filed
September 18, 2024, 7:59 PM ET
On September 17, 2024, the following non-employee directors of the Board of Directors (the “Board”) of 23andMe Holding Co. (the “Company”) resigned from the Board (the “Resignations”), with such Resignations to be effective immediately: Roelof Botha, Patrick Chung, Sandra Hernández, M.D., Neal Mohan, Valerie Montgomery Rice, M.D., Richard Scheller, Ph.D., and Peter J. Taylor (collectively, the “Resigning Directors”).
Departed
Peter Ingram
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Craig Vosburg
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Earl Fry
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Jayne Hrdlicka
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Richard Zwern
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Lawrence Hershfield
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Shannon Okinaka
Other Named Officer
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Peter Ingram, Aaron Alter and Shannon Okinaka resigned from their positions as officers of Hawaiian.
Departed
Crystal Rose
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Wendy Beck
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Aaron Alter
Other Named Officer
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Peter Ingram, Aaron Alter and Shannon Okinaka resigned from their positions as officers of Hawaiian.
Departed
Michael McNamara
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Peter Ingram
Other Named Officer
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Successor
Joseph Sprague
Filed
September 18, 2024, 7:59 PM ET
Peter Ingram, Aaron Alter and Shannon Okinaka resigned from their positions as officers of Hawaiian.
Departed
John E. Bailey, Jr.
Other Named Officer
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Mark Avagliano, Rajesh K. Malik, M.D., Terry L. Murdock, and John W. Umstead V ceased serving as an officer of the Company
Departed
John E. Bailey, Jr.
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Departed
Jacks Lee
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Departed
Cynthia L. Flowers
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Departed
Mark Avagliano
Other Named Officer
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Mark Avagliano, Rajesh K. Malik, M.D., Terry L. Murdock, and John W. Umstead V ceased serving as an officer of the Company
Departed
John W. Umstead V
Other Named Officer
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Mark Avagliano, Rajesh K. Malik, M.D., Terry L. Murdock, and John W. Umstead V ceased serving as an officer of the Company
Departed
Rajesh K. Malik, M.D.
Other Named Officer
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Mark Avagliano, Rajesh K. Malik, M.D., Terry L. Murdock, and John W. Umstead V ceased serving as an officer of the Company
Departed
Terry L. Murdock
Other Named Officer
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Mark Avagliano, Rajesh K. Malik, M.D., Terry L. Murdock, and John W. Umstead V ceased serving as an officer of the Company
Departed
Alicia Secor
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Departed
Norman E. Sharpless, M.D.
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Departed
Garry A. Nicholson
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Departed
Glenn P. Muir
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
On September 18, 2024, Five Below, Inc. (the “Company”) and Michael F. Romanko, the Company’s Chief Merchandising Officer, entered into an agreement (the “Cessation Agreement”) providing for Mr. Romanko’s retirement and the cessation of his employment with the Company, effective as of November 17, 2024.
On September 15, 2024, Jonathan Maroko notified Faraday Future Intelligent Electric Inc. (the “Company”) of his decision to resign from his position as Interim Chief Financial Officer of the Company, effective September 20, 2024.
Departed
Shrisha Radhakrishna
Chief Technology Officer and Chief Product Officer
On September 13, 2024, Shrisha Radhakrishna resigned from his positions as Chief Technology Officer and Chief Product Officer of LegalZoom.com, Inc. (the “Company”) to pursue other opportunities, with such resignation to be effective November 15, 2024.
On September 17, 2024, Sarah Bond and Dr. Paul LeBlanc, each members of the Board of Directors (the “Board”) of Chegg, Inc. (the “Company”), notified the Company of their respective decisions to resign from the Board, effective September 18, 2024.
On September 17, 2024, Sarah Bond and Dr. Paul LeBlanc, each members of the Board of Directors (the “Board”) of Chegg, Inc. (the “Company”), notified the Company of their respective decisions to resign from the Board, effective September 18, 2024.
Departed
Stephen Branstetter
Chief Operating Officer
SMARTSHEET INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
On September 13, 2024, Stephen Branstetter, the Chief Operating Officer of Smartsheet Inc. (the "Company") notified the Company of his decision to resign from his position, effective September 18, 2024.
Richard H. Deily who retired as Chief Financial Officer on September 15, 2024
Departed
David Helmreich
Chief Commercial Officer
Innovid Corp.
Effective
2024-08-30
Filed
September 18, 2024, 7:59 PM ET
Innovid Corp. (the “Company”) announces that it has agreed to the terms of a mutual separation agreement dated September 15, 2024 (the “Mutual Separation Agreement”), which is expected to become effective as of September 21, 2024, by and between the Company and its former Chief Commercial Officer, David Helmreich, who left the Company by mutual consent effective as of the close of business on August 30, 2024 (the “Separation Date”).
Departed
Tracy Layney
Executive Vice President and Chief Human Resources Officer
On September 13, 2024, Crinetics Pharmaceuticals, Inc. (the “Company”) determined that James Hassard will separate from the Company and will cease serving as the Chief Commercial Officer, effective October 14, 2024.
Departed
Vittal Vasista
Executive Vice President, Chief Financial Officer and Principal Accounting Officer
the Board accepted the resignation of Vittal Vasista from his position as Executive Vice President, Chief Financial Officer and Principal Accounting Officer, effective as of September 16, 2024
On September 12, 2024, Mark Bach, M.D., Ph.D. entered into a separation and consulting agreement (the “Bach Separation and Consulting Agreement”) with Structure Therapeutics Inc. (the “Company”) in connection with his departure as Chief Medical Officer (“CMO”) as part of a planned succession, effective as of September 18, 2024 (the “Effective Date”).
On September 16, 2024, Linda Jojo, Executive Vice President and Chief Customer Officer of United Airlines Holdings, Inc. (the “Company”), the parent company of United Airlines, Inc., informed the Company of her intention to retire from the Company, effective January 2, 2025.
On September 16, 2024, James J. Marino, a member of the Board of Directors (the “Board”) of Traws Pharma, Inc. (the “Company”), resigned as a director.
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.